North Macedonia vs Zambia: Share of one-year-olds vaccinated against Haemophilus influenzae type B
North Macedonia
91.0%
in 2024
Zambia
91.0%
in 2024
North Macedonia rank
91st
Zambia rank
91st
Share of one-year-olds vaccinated against Haemophilus influenzae type B over time
- North Macedonia
- Zambia
How they compare
North Macedonia currently reports 91.0% against 91.0% in Zambia, a difference of 0.0%.
The two have swapped places 4 times across 17 shared years of data; in 2008 it was Zambia ahead.
North Macedonia ranks 91st and Zambia ranks 91st of 192 countries.
Across the 3 decades both report, North Macedonia averaged higher in 1 and Zambia in 2.
Head to head by decade
| Decade | North Macedonia | Zambia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 47.5% | 90.5% | 43.0% | Zambia |
| 2010s | 93.0% | 86.4% | 6.6% | North Macedonia |
| 2020s | 85.2% | 89.6% | 4.4% | Zambia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher share of one-year-olds vaccinated against haemophilus influenzae type b, North Macedonia or Zambia?
- North Macedonia, at 91.0% against 91.0% in Zambia as of 2024.
- What is the difference in share of one-year-olds vaccinated against haemophilus influenzae type b between North Macedonia and Zambia?
- 0.0%, with North Macedonia ahead.
- How many years of comparable data are there for North Macedonia and Zambia?
- 17 years are reported by both, from 2008 to 2024.
- How do North Macedonia and Zambia rank globally for share of one-year-olds vaccinated against haemophilus influenzae type b?
- North Macedonia ranks 91st and Zambia ranks 91st of 192 countries.
- Where does this data come from?
- WHO & UNICEF (2025); UN, World Population Prospects (2024) – processed by Our World in Data, published as Share of one-year-olds vaccinated against Haemophilus influenzae type B. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Share of one-year-olds who have had three doses of Haemophilus influenzae type b vaccine in a given year.